Moreover, a previously characterized OCT4/SOX2/NANOG embryonic stem cell expression signature [11] effectively separated SCCs from lung adenocarcinomas when analyzed in publicly available NSCLC microarray datasets. The gene discussed is NANOG; the disease is lung adenocarcinoma.